Gonorrhea and Chlamydia in the United States among Persons 14 to 39 Years of Age, 1999 to 2002
Top Cited Papers
- 17 July 2007
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 147 (2) , 89-96
- https://doi.org/10.7326/0003-4819-147-2-200707170-00007
Abstract
Nationally representative surveys of chlamydia and gonorrhea are an important measure of disease burden and progress of screening programs. To measure chlamydia and gonorrhea prevalence in the United States. Analysis of sexual history information and urine specimens collected in the National Health and Nutrition Examination Survey (NHANES), 1999–2002. U.S. civilian noninstitutionalized population as sampled by NHANES, 1999–2002. 6632 NHANES respondents. Urine specimens were tested for chlamydia and gonorrhea. Results were weighted to represent the U.S. civilian, noninstitutionalized population between 14 and 39 years of age. Prevalence of gonorrheal infection was 0.24% (95% CI, 0.16% to 0.38%). Prevalence of gonorrheal infection was higher among non-Hispanic black persons (1.2% [CI, 0.7% to 1.9%]) than among non-Hispanic white persons (0.07% [CI, 0.02% to 0.24%]). Among those with gonorrheal infection, 46% also had chlamydial infection. Prevalence of chlamydial infection was 2.2% (CI, 1.8% to 2.8%) and was similar between males (2.0% [CI, 1.6% to 2.5%]) and females (2.5% [CI, 1.8% to 3.4%]). Among females, the highest prevalence was in those age 14 to 19 years, whereas among males, it was highest in those age 14 to 29 years. Prevalence was higher among non-Hispanic black persons (6.4% [CI, 5.4% to 7.5%]) than non-Hispanic white persons (1.5% [CI, 1.0% to 2.4%]). Among females with a history of gonorrhea or chlamydia in the previous 12 months, chlamydia prevalence was 16.7% (CI, 5.5% to 50.7%). The specificity of urine-based assays for chlamydia and gonorrhea is limited, and the possible misclassification of sexual experience status may have affected the accuracy of some estimates. The findings support current recommendations to screen sexually active females age 25 years or younger for chlamydia, to retest infected females for chlamydial infection, and to co-treat individuals with gonorrhea for chlamydia.Keywords
This publication has 20 references indexed in Scilit:
- Faculty Opinions recommendation of Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.Published by H1 Connect ,2014
- Indirect Estimation of Chlamydia Screening Coverage Using Public Health Surveillance DataAmerican Journal of Epidemiology, 2004
- Prevalence of Chlamydial and Gonococcal Infections Among Young Adults in the United StatesJAMA, 2004
- The estimated direct medical cost of sexually transmitted diseases among American youth, 2000.Perspectives on Sexual and Reproductive Health, 2004
- Asymptomatic sexually transmitted diseases: the case for screeningPreventive Medicine, 2003
- Risk Behaviors, Medical Care, and Chlamydial Infection Among Young Men in the United StatesAmerican Journal of Public Health, 2002
- Knock‐Knock: A Population‐Based Survey of Risk Behavior, Health Care Access, andChlamydia trachomatisInfection among Low‐Income Women in the San Francisco Bay AreaThe Journal of Infectious Diseases, 2001
- Racial/Ethnic Group Differences in the Prevalence of Sexually Transmitted Diseases in the United States: A Network ExplanationSexually Transmitted Diseases, 1999
- From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infectionSexually Transmitted Infections, 1999
- The ecological effects of individual exposures and nonlinear disease dynamics in populations.American Journal of Public Health, 1994